CT patterns and differential criteria for acute eosinophilic pneumonia and COVID‐19 pneumonia

Kadyrova, Aliya; Antipina, Irina; Kyrbasheva, Indira; Baudinov, Iliar; Kulbaeva, Begaim; Aitieva, Uuljan; Zhunushaliev, Cholponbek; Yethindra, Vityala; Tagaev, Tugolbai

doi:10.1002/ccr3.4890

Cited by 1 publication

(1 citation statement)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). [1][2][3][4][5][6][7][8] Additionally, it has been shown that patients with concomitant chronic illnesses had a greater mortality risk during the pandemic. 9 Angiotensin (Ang) converting enzyme type 2 (ACE2) is expressed on the surface of numerous human cells and shows the affinity of the SARS-CoV-2 S-peptide to this ACE2.…”

Section: Introductionmentioning

confidence: 99%

Role, Impact, and Effect of Angiotensin-converting Enzyme 2 (ACE2) in Patients with COVID-19 under High-altitude Conditions

Vityala

2023

JCD

View full text Add to dashboard Cite

Background: A number of studies on the mechanisms of the positive effect of angiotensin (Ang) converting enzyme type 2 (ACE2) on the general condition of patients with coronavirus disease (COVID-19) reflect its direct correlation with the ACE2 concentration. This study investigated how the high-altitude factor affects angiotensin regulatory systems in patients with COVID-19 in susceptible populations. Materials and Methods:A prospective cohort study of 335 patients with COVID-19 and concomitant arterial hypertension determined general clinical, immunological, and other parameters of health status. Group I included 135 patients of both genders with moderate COVID-19 caused by SARS-CoV-2 and moderate arterial hypertension (AH) who refused anti-hypertensive drugs. Losartan was given to 200 patients of both genders with a laboratory-confirmed mild SARS-CoV-2 infection and moderate AH in Group II.Results: Comparing Group II to Group I, the general condition parameters were found to be noticeably improved in Group II. Additionally, patients in Group II showed positive blood coagulation system dynamics. When comparing Groups I and II, the immune response was seen to be more stable in Group II.Conclusions: Group I patients with ACE2 deficiency set off a chain of events, most of which had to do with how Ang II affected the body by turning on angiotensin type 1 receptors. Observations made in Group II showed a favourable response to Ang-(1-7) and its effects on angiotensin type 2 receptors, Mas receptors, and the lowering of ACE2 bradykinin, blocking the implementation of the pro-inflammatory action through B1 receptors.

show abstract

Section: Introductionmentioning

confidence: 99%

Role, Impact, and Effect of Angiotensin-converting Enzyme 2 (ACE2) in Patients with COVID-19 under High-altitude Conditions

Vityala

2023

JCD

View full text Add to dashboard Cite

show abstract

CT patterns and differential criteria for acute eosinophilic pneumonia and COVID‐19 pneumonia

Abstract: Difficulties encountered in diagnosing and treating COVID‐19 pneumonia and acute eosinophilic pneumonia during the pandemic from 2019 to 2021 led to the identification and study of the differential features of the two conditions.

Cited by 1 publication

References 21 publications

Role, Impact, and Effect of Angiotensin-converting Enzyme 2 (ACE2) in Patients with COVID-19 under High-altitude Conditions

Role, Impact, and Effect of Angiotensin-converting Enzyme 2 (ACE2) in Patients with COVID-19 under High-altitude Conditions

Contact Info

Product

Resources

About